首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1345399

全球血壓計市場 - 2023-2030

Global Sphygmomanometer Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球血壓計市場規模達到28億美元，預計到2030年將實現利潤豐厚的成長，達到52億美元。預計全球血壓計市場在預測期內（2023-2030年）年複合成長率為8.3 % ）。家庭護理環境中擴大採用血壓計是市場的主要趨勢之一。

血壓計由纏繞在手臂上的橡膠杯、橡膠杯固有的燈泡、釋放壓力的閥門以及測量橡膠杯壓力的測量儀器組成。數位或電子血壓計採用示波測量方法。它操作簡單、電池供電、自動化且不含汞。

數位血壓計包括手動、自動、腕式、上臂式、新生兒和兒童血壓計。最常用的血壓計是腕式血壓計和自動數位血壓計。

市場動態

血壓計的技術進步

血壓計對於評估血壓以進行診斷和管理至關重要，審查的重點是其功能和技術進步。消費者醫療保健領域的技術進步，例如穿戴式技術、應用程式和手機的創新，以及零售商和製造商平均售價的降低，正在推動公司的成長。

Microlife WatchBP home A、QardioArm、LifeSource Sophisticated 一步式自動充氣血壓監測儀和 Omron Healthcare 的 iHealth 血壓監測儀是市場上技術最先進的數位血壓監測儀。 Omron Healthcare 是一家著名的數位血壓監測儀製造商，包括 Omron Platinum 和 Evolv 無線上臂監測儀。

家庭護理環境中擴大採用血壓計

在過去幾年中，遠程醫療的使用有所增加。儘管 COVID-19 大流行是導致人們從定期就診轉向虛擬就診的原因，但患者很快意識到遠程醫療還有其他優勢。遠程醫療可以提供醫生以前尋求的精確、及時的醫療建議。隨著遠程醫療的日益普及，家庭監測血壓等健康數據的需求變得至關重要。

家庭護理環境中的血壓計通過允許患者在家中測試血壓來提供便利、可及性並改善健康結果。這可以實現更頻繁的監測、改善高血壓控制、早期診斷和避免異常、及時治療和個性化護理。家庭血壓監測還可以減少就診次數，避免出現問題和住院治療，從而具有成本效益。

市場競爭加劇

阻礙血壓計市場成長的主要因素之一是供應商之間的激烈競爭以及未經授權產品的存在。由於一些新的小公司以及成熟供應商的存在，該行業的競爭變得異常激烈。大多數血壓計在形式和技術上都具有可比性，並且可以從國外和本地供應商處購買。跨國公司在行銷、促銷和品牌品質開發方面投入大量資金，以實現利潤率最大化。

COVID-19 影響分析

COVID-19將對血壓計行業產生巨大影響，因為由於病毒性疾病的間接傳播，高血壓患者更容易受到感染。醫療保健從業人員常用的血壓計含有可能通過人體皮膚傳播的病菌和細菌。因此，能夠在不冒感染風險的情況下測試和監測自己的血壓將增加市場收入。

俄烏戰爭影響分析

俄羅斯和烏克蘭的衝突增加了慢性非傳染性疾病的醫療負擔，而此前慢性非傳染性疾病所佔比例最大。消極的應對技巧，如增加飲酒和吸煙，加劇了這些健康問題，可能增加心血管風險，尤其是高血壓，並增加未來對血壓計的需求。

Overview

The global Sphygmomanometer market reached US$ 2.8 billion in 2022 and is estimated to witness lucrative growth by reaching up to US$ 5.2 billion by 2030. The global Sphygmomanometer market is expected to exhibit a CAGR of 8.3% during the forecast period (2023-2030). Increasing adoption of Sphygmomanometers in homecare settings is one of the key trend of the market.

A sphygmomanometer consists of a rubber cup wrapped around the arm, a bulb to innate the cup, a valve to release the pressure, and a measuring instrument to measure the cup's pressure. A digital or electronic sphygmomanometer employs an oscillometric measurement approach. It is simple to operate, battery-powered, automated, and mercury-free.

Digital sphygmomanometers include manual, automatic, wrist, upper arm, neonatal, and paediatric sphygmomanometers. The most often used sphygmomanometers are wrist and automated digital sphygmomanometers.

Market Dynamics

Technological Advancements in Sphygmomanometers

Sphygmomanometers are crucial for assessing blood pressure for diagnosis and management, with reviews focusing on their functionality and advancements in technology. Technological advancements in the consumer healthcare category, such as innovations in wearable technology, apps, and mobiles, as well as reducing average selling prices for retailers and manufacturers, are boosting firm growth.

Microlife WatchBP home A, QardioArm, LifeSource Sophisticated one-step auto inflate blood pressure monitor, and Omron Healthcare's iHealth blood pressure monitor are some of the most technologically sophisticated digital BP monitors on the market. Omron Healthcare is a well-known manufacturer of digital blood pressure monitors, including the Omron Platinum and Evolv Wireless Upper Arm Monitors.

Increasing Adoption of Sphygmomanometers In Homecare Settings

Over the previous few years, telehealth usage has increased. Patients quickly realized that there were additional advantages to telemedicine, despite the fact that the COVID-19 pandemic was the reason for the move from regular clinic visits to virtual ones. Telemedicine can deliver precise and prompt healthcare suggestions that were previously sought by a doctor. With this rising adoption of telehealth, the need for at-home monitoring of health data such as blood pressure has become crucial.

Sphygmomanometers in homecare settings provide convenience, accessibility, and improved health outcomes by allowing patients to test their blood pressure at home. This results in more frequent monitoring, improved hypertension control, early diagnosis and avoidance of anomalies, prompt treatments, and personalised care. Home blood pressure monitoring also decreases clinic visits and avoids problems and hospitalisations, making it cost-effective.

Increasing Competition in the Market

One of the primary factors hindering the growth of the sphygmomanometer market is strong competition among providers, as well as the presence of unauthorised products. The industry has grown extremely competitive as a result of the existence of several new and small firms, as well as well-established vendors. The majority of sphygmomanometers are comparable in form and technology, and they are available from both foreign and local vendors. Multinational firms invest much in marketing, promotion, and brand quality development to maximise their profit margins.

COVID-19 Impact Analysis

COVID-19 will had a numerous impact on the sphygmomanometer industry since people with high blood pressure will be more susceptible to infection owing to the indirect transmission of viral illnesses. Blood pressure monitors are commonly used by healthcare practitioners and contain germs and bacteria that may be transmitted through human skin. As a result, being able to test and monitor one's own blood pressure without risking infection will boost market revenue.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has increased the healthcare burden for chronic noncommunicable illnesses, which previously accounted for the largest portion. Negative coping techniques, like increased alcohol use and smoking, have exacerbated these health concerns, potentially increasing cardiovascular risks, especially hypertension, and increasing the need for sphygmomanometers in the future.

Segment Analysis

The global sphygmomanometer is segmented based on product, operation, configuration, end user and region.

HomeCare Settings From the End User Segment Accounts for 37.3% of Market Share Owing to Rising Novel Product Launches

The homecare settings from the end user segment with around 37.3% is expected to dominate during the forecast period owing to an increase in the usage of homecare digital sphygmomanometers with sophisticated technology that can communicate patient information wirelessly to clinicians.

For instance, in January 2022, OMRON Healthcare, Inc., a subsidiary of OMRON Corporation, launched Remote Patient Monitoring Services. The service would broaden Digital Health Services to support consumers on each step of their heart health journey. Moreover, this service is created to strengthen the guide behaviour change, patient-physician connection, and reducing risk.

Geographical Analysis

Asia Pacific estimated to hold for Approximately 38.4% of the Market Share

Asia Pacific is estimated to hold about 38.4% of the total market share in the forecasted period, due to the availability of untapped potential, growing hypertension prevalence, and rising awareness levels, is expected to rise substantially over the projected period.

Rapidly improving healthcare facilities, as well as a rise of misdiagnosed patients, are driving regional market expansion. Government efforts to improve public awareness, as well as a rapidly growing target disease population base, are all contributing to the lucrative expansion of this area's BP monitoring devices industry.

For instance, in March 2023, Xiaomi launched the MIJIA electronic blood pressure monitor in China, also known as the MIJIA Electronic Sphygmomanometer. This tie-free device measures blood pressure with just one clamp and stick, eliminating the need for repeated cuff adjustments.

Competitive Landscape

The major global players in the sphygmomanometer include: OMRON Corporation, 3B Scientific, Acoma Medical Industry Co, AmbulanceMed, American Diagnostic Corporation, Amico Group of Companies, A D Company Ltd, Bremed Ltd., CIGA Healthcare Ltd, HEINE Optotechnik GmbHCo. KG and among others.

Why Purchase the Report?

To visualize the global sphygmomanometer market segmentation based on product, operation, configuration, end user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of sphygmomanometer market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global sphygmomanometer report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Operation
3.3. Snippet by Configuration
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements in Sphygmomanometers
  - 4.1.1.2. Increasing Adoption of Sphygmomanometers In Homecare Settings
- 4.1.2. Restraints
  - 4.1.2.1. Increasing Competition in the Market
- 4.1.3. Opportunity
  - 4.1.3.1. Growth Opportunities in Emerging Markets
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Electronic Sphygmomanometer*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Aneroid Sphygmomanometer
7.4. Mercury Sphygmomanometer

8. By Operation

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
- 8.1.2. Market Attractiveness Index, By Operation
8.2. Automatic *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Semi automatic
8.4. Others

9. By Configuration

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
- 9.1.2. Market Attractiveness Index, By Configuration
9.2. Portable *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Desk Mounted
9.4. Floor standing
9.5. Wall Mounted

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Homecare

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Spain
  - 11.3.7.5. Italy
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Configuration
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. OMRON Corporation*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. 3B Scientiifc
13.3. Acoma Medical Industry Co
13.4. AmbulanceMed
13.5. American Diagnostic Corporation
13.6. Amico Group of Companies
13.7. A D Company Ltd
13.8. Bremed Ltd.
13.9. CIGA Healthcare Ltd
13.10. HEINE Optotechnik GmbHCo. KG

LIST NOT EXHAUSTIVE